Black Swan Graphene has reported performance results from production-scale trials conducted by one of its partners, a global masterbatch manufacturer, including testing at end-customer facilities.
For one marquee consumer-products program, Black Swan was advised that its graphene-enhanced formulation delivered superior results versus alternative materials evaluated by that specific customer, reinforcing the Company's view that its approach to Graphene-Enhanced Masterbatch™ ("GEM™") is highly competitive in targeted high-volume applications. Customers and application details have not been disclosed for commercial reasons, according to Black Swan Graphene.
In the consumer packaging sector, trials with a major customer for polyethylene terephthalate ("PET") bottles and films reportedly demonstrated significant improvements in oxygen and water vapor barrier properties. Based on the results, the customer is moving forward with additional diligence and commercial dialogues toward a possible long-term supply arrangement, citing Black Swan's formulation as delivering superior results to alternative graphene manufacturers.
In support of this opportunity, Black Swan has recently initiated a full Food and Drug Administration ("FDA") approval process with a globally recognized third-party testing and certification body. While there can be no guarantee, securing FDA food-contact clearance via an effective Food Contact Notification (FCN) would represent an important milestone for the Company, paving the way for the widespread commercialization of graphene-enhanced packaging solutions across global supply chains.
Validation also extends to the high-performance plastics sector, where trials in automotive applications using polypropylene ("PP") and polyamide ("PA") polymers have delivered highly encouraging results. The graphene-enhanced materials demonstrated significantly improved impact resistance along with notable lightweighting benefits - two critical factors for advancing both fuel efficiency and safety in modern vehicles. These attributes align directly with the automotive industry's drive toward electrification and sustainability, where stronger, lighter materials play a pivotal role.
In parallel, the construction sector is showing similar promise. Trials with PP pipes revealed excellent lightweighting - or "downgauging" - potential, enabling manufacturers to reduce material usage and costs without sacrificing structural integrity. Such advances underscore graphene's ability to enhance performance while supporting more sustainable and resource-efficient manufacturing practices.
"First, although we are unable to identify the customers, the engagements are with a globally recognized brand. The commercial potential is notable, and we are moving forward with discipline and discretion. Second, we are achieving exactly what we set out to prove: with the right dispersion and the right loading, our graphene products can unlock properties that matter at industrial scale. These partner-led trials validate the strength of our GEM model confirming that we can provide a reliable pathway for global manufacturers to integrate graphene seamlessly into existing production processes. Importantly, the results demonstrate not only technical performance, but also commercial viability, positioning Black Swan to capture significant near-term opportunities as we advance toward high-volume production. This is a powerful testament to the commercial readiness of our graphene solutions," said Simon Marcotte, President & Chief Executive Officer of Black Swan.
Black Swan has initiated a major capacity expansion at its UK site to approximately 140 tonnes per year, to support volume adoption. The expansion leverages existing infrastructure to minimize capex and accelerate time to output.
"Volume and price are decisive in the markets we are targeting. With our installed and expanding capacity, our GEM strategy, and our global partner network, we believe we are equipped to deliver both at scale," said Michael Edwards, Chief Operating Officer of Black Swan.
